- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03614260
Lo studio cardine RADIANCE II: uno studio del sistema ReCor Medical Paradise nell'ipertensione di stadio II (RADIANCE-II)
The objective of the RADIANCE II Pivotal study is to demonstrate the effectiveness and safety of the Paradise System in subjects with Stage 2 hypertension on 0-2 medications at the time of consent. Prior to randomization, subjects will be hypertensive in the absence of hypertension medication.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Brussels, Belgio, 1000
- Centre Hospitalier Universitaire Saint-Pierre
-
-
-
-
-
Bordeaux, Francia, 33000
- Hôpital Saint André
-
Lille, Francia, 59000
- CHRU de Lille
-
Paris, Francia, 75015
- Hôpital Européen Georges-Pompidou (HEGP)
-
-
-
-
-
Erlangen, Germania, D-91054
- University Clinic Erlangen
-
Homburg, Germania, D-66421
- University Clinic of Saarland - Homburg
-
Karlsruhe, Germania, 76133
- Klinikum Karlsruhe GmbH
-
Konstanz, Germania, D-78464
- Klinikum Konstanz
-
Leipzig, Germania, D-04289
- Herzzentrum Leipzig GmbH
-
Lübeck, Germania, D-23560
- Sana Kliniken Lübeck GmbH
-
-
-
-
-
Galway, Irlanda, H91 YR71
- University Hospital Galway
-
-
-
-
-
Rotterdam, Olanda, 3015 GD
- Erasmus Medical Center
-
-
-
-
-
Bournemouth, Regno Unito, BH7 7DW
- University Hospitals Dorset NHS Foundation Trust
-
Canterbury, Regno Unito, CT1 3NG
- Kent & Canterbury Hospital
-
Cardiff, Regno Unito
- University Hospital Wales
-
London, Regno Unito, EC1A 7BE
- St Bartholomew's Hospital
-
Newcastle upon Tyne, Regno Unito, NE7 7DN
- Freeman Hospital
-
-
Essex
-
Basildon, Essex, Regno Unito, SS16 5NL
- The Cardiothoracic Centre Basildon University Hospital
-
-
-
-
Alabama
-
Birmingham, Alabama, Stati Uniti, 35211
- Cardiology PC
-
-
California
-
Los Angeles, California, Stati Uniti, 940048
- Cedars Sinai Medical Center
-
-
Connecticut
-
Bridgeport, Connecticut, Stati Uniti, 06610
- Bridgeport Hospital
-
Stamford, Connecticut, Stati Uniti, 06904
- Stamford Hospital
-
-
District of Columbia
-
Washington D.C., District of Columbia, Stati Uniti, 20010
- MedStar Washington
-
-
Florida
-
Gainsville, Florida, Stati Uniti, 32605
- The Cardiac and Vascular Institute
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30308
- Emory University Hospital Midtown
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60611
- Northwestern University
-
Springfield, Illinois, Stati Uniti, 62794
- Southern Illinois University
-
-
Louisiana
-
New Orleans, Louisiana, Stati Uniti, 70121
- Ochsner Heart and Vascular Institute
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02120
- The Brigham and Women's Hospital
-
-
Michigan
-
Traverse City, Michigan, Stati Uniti, 49684
- Munson Medical Center
-
-
Minnesota
-
Minneapolis, Minnesota, Stati Uniti, 55407
- Minneapolis Heart Institute Foundation
-
-
Missouri
-
Kansas City, Missouri, Stati Uniti, 64111
- Saint Luke's Health System
-
-
Nevada
-
Reno, Nevada, Stati Uniti, 89502
- Renown Regional Medical Center
-
-
New Jersey
-
Browns Mills, New Jersey, Stati Uniti, 08015
- Deborah Heart & Lung Center
-
Hackensack, New Jersey, Stati Uniti, 07601
- Hackensack University
-
-
New York
-
New York, New York, Stati Uniti, 10032
- Columbia University Medical Center/NYPH
-
New York, New York, Stati Uniti, 10075
- Northwell Health Inc.
-
-
North Carolina
-
Chapel Hill, North Carolina, Stati Uniti, 27599
- The University of North Carolina at Chapel Hill
-
-
Ohio
-
Cleveland, Ohio, Stati Uniti, 44195
- Cleveland Clinic
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Stati Uniti, 19104
- University of Pennsylvania Health System
-
Pittsburgh, Pennsylvania, Stati Uniti, 15213
- University of Pittsburgh Medical Center
-
-
South Carolina
-
Charleston, South Carolina, Stati Uniti, 29425
- Medical University of South Carolina
-
-
Tennessee
-
Memphis, Tennessee, Stati Uniti, 38163
- The University of Tennessee Health Science Center
-
Nashville, Tennessee, Stati Uniti, 37232
- Vanderbilt University
-
-
Utah
-
Salt Lake City, Utah, Stati Uniti, 84132
- University of Utah
-
-
Washington
-
Seattle, Washington, Stati Uniti, 98122
- Swedish Medical Center
-
-
-
-
-
Geneva, Svizzera, 1211
- Hôpitaux Universitaires Genève
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Previously or currently prescribed antihypertensive therapy
- Average office BP ≥ 140/90 mmHg <180/120 mmHg while stable for at least 4 weeks on 0-2 classes of antihypertensive medication
- Documented daytime ABP ≥ 135/85 mmHg and < 170/105 mmHg after 4-week washout/run-in period
Exclusion Criteria:
- Lacks appropriate renal artery anatomy for treatment
- Known, uncorrected causes of secondary hypertension other than sleep apnea
- Type I diabetes mellitus or uncontrolled Type II diabetes
- eGFR of <40
- Brachial circumference ≥ 42 cm
- Any history of cerebrovascular event or severe cardiovascular event, or history of stable or unstable angina within 12 months prior to consent
- Repeat (>1) hospitalization for hypertensive crisis within 12 months prior to screening period, or any hospitalization for hypertensive crisis within 3 months prior to screening period
- Chronic oxygen support or mechanical ventilation other than nocturnal respiratory support for sleep apnea
- Primary pulmonary hypertension
- Night shift workers
- Pregnant, nursing or planning to become pregnant
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Renal Denervation
Renal Angiogram and Renal Denervation (Paradise Renal Denervation System) |
Following renal angiogram according to standard procedures, subjects remain blinded and are immediately treated with the renal denervation procedure after randomization.
Altri nomi:
|
|
Comparatore fittizio: Sham Control
Renal Angiogram |
Following renal angiogram to standard procedures, subjects remain blinded and renal angiogram is considered the sham procedure. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Average Daytime Ambulatory Systolic BP
Lasso di tempo: From baseline to 2 months post-procedure
|
The primary efficacy outcome is the mean change in daytime ambulatory systolic blood pressure at 2 months |
From baseline to 2 months post-procedure
|
|
Percentage of Participants With Major Adverse Events (MAE)
Lasso di tempo: From baseline to 30 days post-procedure
|
The primary safety composite outcome of major adverse events included death, kidney failure, and major embolic, vascular, cardiovascular, cerebrovascular, and hypertensive events at 30 days. |
From baseline to 30 days post-procedure
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Average 24-hr Ambulatory Systolic BP
Lasso di tempo: From baseline to 2 months post-procedure
|
Change in average 24-hr ambulatory systolic blood pressure |
From baseline to 2 months post-procedure
|
|
Change in Average Office Systolic BP
Lasso di tempo: From baseline to 2 months post-procedure
|
Change in average office systolic blood pressure |
From baseline to 2 months post-procedure
|
|
Change in Average Home Systolic BP
Lasso di tempo: From baseline to 2 months post-procedure
|
Change in average home systolic blood pressure |
From baseline to 2 months post-procedure
|
|
Change in Average Daytime Ambulatory Diastolic BP
Lasso di tempo: From baseline to 2 months post-procedure
|
Change in average daytime ambulatory diastolic blood pressure |
From baseline to 2 months post-procedure
|
|
Change in Average 24-hr Ambulatory Diastolic BP
Lasso di tempo: From baseline to 2 months post-procedure
|
Change in average 24-hr ambulatory diastolic blood pressure |
From baseline to 2 months post-procedure
|
|
Change in Average Office Diastolic BP
Lasso di tempo: From baseline to 2 months post-procedure
|
Change in average office diastolic blood pressure |
From baseline to 2 months post-procedure
|
|
Change in Average Home Diastolic BP
Lasso di tempo: From baseline to 2 months post-procedure
|
Change in average home diastolic blood pressure |
From baseline to 2 months post-procedure
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Ajay Kirtane, MD, SM, Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation
- Investigatore principale: Prof. Michel Azizi, MD, PhD, Professor of Vascular Medicine, Hypertension Dept. and Clinical Investigation Center, Hôpital Européen Georges Pompidou
Pubblicazioni e link utili
Pubblicazioni generali
- Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, Fisher NDL, Schmieder RE, Mahfoud F, Lindsey J, Sanghvi K, Todoran TM, Pacella J, Flack J, Daemen J, Sharp ASP, Lurz P, Bloch MJ, Weber MA, Lobo MD, Basile J, Claude L, Reeve-Stoffer H, McClure CK, Kirtane AJ; RADIANCE II Investigators and Collaborators. Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial. JAMA. 2023 Feb 28;329(8):651-661. doi: 10.1001/jama.2023.0713.
- Azizi M, Sharp ASP, Fisher NDL, Weber MA, Lobo MD, Daemen J, Lurz P, Mahfoud F, Schmieder RE, Basile J, Bloch MJ, Saxena M, Wang Y, Sanghvi K, Jenkins JS, Devireddy C, Rader F, Gosse P, Claude L, Augustin DA, McClure CK, Kirtane AJ; RADIANCE Investigators. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program. Circulation. 2024 Mar 5;149(10):747-759. doi: 10.1161/CIRCULATIONAHA.123.066941. Epub 2023 Oct 26.
- Kirtane AJ, Sharp ASP, Mahfoud F, Fisher NDL, Schmieder RE, Daemen J, Lobo MD, Lurz P, Basile J, Bloch MJ, Weber MA, Saxena M, Wang Y, Sanghvi K, Jenkins JS, Devireddy C, Rader F, Gosse P, Sapoval M, Barman NC, Claude L, Augustin D, Thackeray L, Mullin CM, Azizi M; RADIANCE Investigators and Collaborators. Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. JAMA Cardiol. 2023 May 1;8(5):464-473. doi: 10.1001/jamacardio.2023.0338.
- Bytyqi V, Kannenkeril D, Striepe K, Bosch A, Karg MV, Schmid A, Schiffer M, Uder M, Schmieder RE. Predicting blood pressure response to renal denervation based on a new approach. J Hypertens. 2025 Mar 1;43(3):413-419. doi: 10.1097/HJH.0000000000003918. Epub 2024 Oct 29.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- RADIANCE II Study
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .